Therapeutic Advances in Psychopharmacology
Published by SAGE
ISSN : 2045-1253 eISSN : 2045-1261
Abbreviation : Ther. Adv. Psychopharmacol.
Aims & Scope
Therapeutic Advances in Psychopharmacology delivers the highest quality peer-reviewed open access articles, reviews, and scholarly comment on pioneering efforts and innovative studies across all areas of psychopharmacology.
The journal has a strong clinical and pharmacological focus and is aimed at an international audience of clinicians and researchers in psychopharmacology, providing an online forum for rapid dissemination of recent research and perspectives in this area.
The editors welcome original research articles across all areas of psychopharmacology.
The journal is dedicated to publishing clinical research.
We do not publish preclinical research, including basic laboratory research and animal studies.
View Aims & ScopeMetrics & Ranking
Impact Factor
| Year | Value |
|---|---|
| 2025 | 4 |
| 2024 | 3.40 |
Journal Rank
| Year | Value |
|---|---|
| 2024 | 3624 |
Journal Citation Indicator
| Year | Value |
|---|---|
| 2024 | 498 |
SJR (SCImago Journal Rank)
| Year | Value |
|---|---|
| 2024 | 1.187 |
Quartile
| Year | Value |
|---|---|
| 2024 | Q1 |
h-index
| Year | Value |
|---|---|
| 2024 | 46 |
Impact Factor Trend
Abstracting & Indexing
Journal is indexed in leading academic databases, ensuring global visibility and accessibility of our peer-reviewed research.
Subjects & Keywords
Journal’s research areas, covering key disciplines and specialized sub-topics in Medicine, designed to support cutting-edge academic discovery.
Licensing & Copyright
This journal operates under an Open Access model. Articles are freely accessible to the public immediately upon publication. The content is licensed under a Creative Commons Attribution 4.0 International License (CC BY 4.0), allowing users to share and adapt the work with proper attribution.
Copyright remains with the author(s), and no permission is required for non-commercial use, provided the original source is cited.
Policy Links
This section provides access to essential policy documents, guidelines, and resources related to the journal’s publication and submission processes.
- Aims scope
- Homepage
- Oa statement
- Author instructions
- License terms
- Review url
- Board url
- Copyright url
- Plagiarism url
- Preservation url
- Apc url
- License
Plagiarism Policy
This journal follows a plagiarism policy. All submitted manuscripts are screened using reliable plagiarism detection software to ensure originality and academic integrity. Authors are responsible for proper citation and acknowledgment of all sources, and any form of plagiarism, including self-plagiarism, will not be tolerated.
For more details, please refer to our official: Plagiarism Policy.
APC Details
The journal’s Article Processing Charge (APC) policies support open access publishing in Medicine, ensuring accessibility and quality in research dissemination.
This journal requires an Article Processing Charge (APC) to support open access publishing, covering peer review, editing, and distribution. The current APC is 2,650.00 USD. Learn more.
Explore journals without APCs for alternative publishing options.
Most Cited Articles
The Most Cited Articles section features the journal's most impactful research, based on citation counts. These articles have been referenced frequently by other researchers, indicating their significant contribution to their respective fields.
-
Medication adherence in schizophrenia: factors influencing adherence and consequences of nonadherence, a systematic literature review
Citation: 448
Authors: Kyoko, Goran, Kavi J., Teresa, Ola, Marc
-
Cannabis, a complex plant: different compounds and different effects on individuals
Citation: 441
Authors: Zerrin
-
New psychoactive substances: a review and updates
Citation: 248
Authors: Abu, Alex J., Harry, David M., Derek K.
-
The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal
Citation: 237
Authors: Sofia, Miguel Ruiz, David, Vicent
-
Antidepressive, anxiolytic, and antiaddictive effects of ayahuasca, psilocybin and lysergic acid diethylamide (LSD): a systematic review of clinical trials published in the last 25 years
Citation: 225
Authors: Rafael G., Flávia L., José Alexandre S., Jordi, Antônio W., Jaime E. C.
-
The acute efficacy of antipsychotics in schizophrenia: a review of recent meta-analyses
Citation: 192
Authors: Peter M., Christoph U.
-
The drugs don’t work? antidepressants and the current and future pharmacological management of depression
Citation: 166
Authors: Elizabeth, Derek K.
-
Bupropion: a systematic review and meta-analysis of effectiveness as an antidepressant
Citation: 153
Authors: Krisna, Sophie, Mariam N., Ilinca, David, Derek K.
-
Frontotemporal dementia: latest evidence and clinical implications
Citation: 145
Authors: Juan Joseph, Mallika, Deena, Silpa, Rajesh R.